The launch of the world’s first Malaria vaccine in Malawi, to be followed in the coming weeks in Ghana and Kenya, is offering a ray of hope for Nigeria, which currently leads in the global malaria burden.
Nigeria accounted for about 55 million malaria cases, which represented 25 percent of case
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
CALEB OJEWALE
Caleb Ojewale is an Assistant Editor at BusinessDay Newspaper in Nigeria, where he also heads Industry and Real Sector, supervising all associated beats/desks.
He is concurrently Editor for Features, Interviews, and the Newspaper's Backpage (Monday to Thursday). He has also been OP-ED Editor and a member of the Editorial Board.
A well rounded business journalist; he is a recipient of multiple local and international journalism awards.
Caleb is a fellow of the University of Oxford and OKP and has bachelor’s and Master's degrees in communication from Lagos State University and the University of Lagos, respectively.
